This is a news story, published by Phys Org, that relates primarily to * University of Alberta news.
For more biology news, you can click here:
more biology newsFor more news from Phys Org, you can click here:
more news from Phys OrgOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
drug delivery technologies. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest lipid nanoparticle news, gene therapy news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
vivo deliveryPhys Org
•
85% Informative
University of Alberta -led discovery uses viruses to transport gene therapies past liver.
FAST-PLV avoids liver, allowing therapies to more effectively target areas such as brain and lungs.
Trials for Stargardt's disease could begin within the next two years , while ongoing research into cancer treatments is already underway.
VR Score
84
Informative language
85
Neutral language
39
Article tone
semi-formal
Language
English
Language complexity
74
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
5
Affiliate links
no affiliate links